枸橼酸钾与枸橼酸对磷酸钙结石患者尿液成石风险的影响
该交叉代谢研究纳入13例无高钙尿症的复发性磷酸钙结石患者,比较枸橼酸30 mEq每日两次、枸橼酸钾20 mEq每日两次与安慰剂对尿液成分及磷酸钙饱和度的影响。结果显示枸橼酸未显著改变尿液参数,而枸橼酸钾显著升高尿pH、钾和枸橼酸,但对磷酸钙饱和度的长期影响需进一步研究。
要点
- 枸橼酸60 mEq/日未显著改变磷酸钙结石患者的尿液成分。
- 枸橼酸钾显著升高尿pH、钾和枸橼酸,尿钙有降低趋势。
- 枸橼酸钾对磷酸钙结石复发的长期影响尚不明确。
核心结论
- 枸橼酸60 mEq/日未显著改变磷酸钙结石患者的尿液成分。
- 枸橼酸钾对磷酸钙结石复发的长期影响需进一步研究。
研究设计与样本
- 交叉代谢研究,纳入13例无高钙尿症的复发性磷酸钙结石患者。
- 患者接受固定代谢饮食,分别服用枸橼酸30 mEq每日两次、枸橼酸钾20 mEq每日两次或安慰剂,每阶段1周。
主要发现
- 枸橼酸与安慰剂阶段的尿液参数无显著差异。
- 枸橼酸钾较枸橼酸和安慰剂显著升高尿pH、钾和枸橼酸(p<0.01),尿钙有降低趋势(p=0.062)。
- 枸橼酸钾使相对过饱和比值计算的透钙磷石饱和度增加,但饱和指数计算未显示增加。
临床怎么用
- 对于无高钙尿症的复发性磷酸钙结石患者,枸橼酸60 mEq/日可能无法改善尿液成石风险。
- 枸橼酸钾可改变尿液成分,但其对磷酸钙结石复发的长期影响尚不明确。
局限性
- 样本量小(13例),研究周期短(每阶段1周)。
- 仅纳入无高钙尿症的复发性磷酸钙结石患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To our knowledge no medication has been shown to be effective for preventing recurrent calcium phosphate urinary stones. Potassium citrate may protect against calcium phosphate stones by enhancing urine citrate excretion and lowering urine calcium but it raises urine pH, which increases calcium phosphate saturation and may negate the beneficial effects. Citric acid can potentially raise urine citrate but not pH and, thus, it may be a useful countermeasure against calcium phosphate stones. We assessed whether these 2 agents could significantly alter urine composition and reduce calcium phosphate saturation. MATERIALS AND METHODS: In a crossover metabolic study 13 recurrent calcium phosphate stone formers without hypercalciuria were evaluated at the end of 3, 1-week study phases during which they consumed a fixed metabolic diet and received assigned study medications, including citric acid 30 mEq twice daily, potassium citrate 20 mEq twice daily or matching placebo. We collected 24-hour urine specimens to perform urine chemistry studies and calculate calcium phosphate saturation indexes. RESULTS: Urine parameters did not significantly differ between the citric acid and placebo phases. Potassium citrate significantly increased urine pH, potassium and citrate compared to citric acid and placebo (p <0.01) with a trend toward lower urine calcium (p = 0.062). Brushite saturation was increased by potassium citrate when calculated by the relative supersaturation ratio but not by the saturation index. CONCLUSIONS: Citric acid at a dose of 60 mEq per day did not significantly alter urine composition in calcium phosphate stone formers. The long-term impact of potassium citrate on calcium phosphate stone recurrence needs to be studied further.
引用
- Doizi S, Poindexter JR, Pearle MS, et al. Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers. J Urol. 2018. PMID: 30036516. doi:10.1016/j.juro.2018.07.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。